CSIMarket



Allovir Inc.  (ALVR)
Other Ticker:  
 

Cumulative Allovir's Quick Ratio for Trailing Twelve Months Period

ALVR's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ALVR Quick Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Current Liabilities Growth 4.25 % 20.25 % 207.9 % 78.78 % 132.28 %
Y / Y Cash & cash equivalent Growth -44.89 % -40.24 % -30.37 % -27.12 % 199.98 %
Quick Ratio for Trailing Twelve Months Period 8.78 10.25 11.95 17.65 22.33
Total Ranking # 499 # 457 # 401 # 185 # 112
Seq. Current Liabilities Growth 15.82 % -50.76 % 56.59 % 16.73 % 33.6 %
Seq. Cash & cash equivalent Growth -14.25 % -18.84 % -10.05 % -11.97 % -7.02 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the II. Quarter to $22 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 8.78 below Allovir Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 85 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Allovir. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 457 to 499.

What is Quick Ratio?
Learn more about ALVR
Quick Ratio ALVR in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 86
Sector # 277
S&P 500 # 492


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
25.43 17.11 8.78
(Dec 31 2020)   (Jun 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Vor Biopharma Inc.  23.70 
Organovo Holdings Inc.  23.37 
Replimune Group Inc.  23.16 
Rubius Therapeutics Inc.  23.03 
Freeline Therapeutics Holdings Plc  22.68 
Icosavax Inc.  22.54 
Crispr Therapeutics Ag  21.76 
Lixte Biotechnology Holdings Inc.  21.35 
Fusion Pharmaceuticals Inc.  18.59 
4d Molecular Therapeutics Inc.  18.52 
Citius Pharmaceuticals Inc.  18.03 
Salarius Pharmaceuticals inc.  18.02 
Rapt Therapeutics Inc.  17.86 
Biorestorative Therapies Inc.  17.82 
Kymera Therapeutics Inc.  17.82 
Century Therapeutics inc.  17.56 
Tarsus Pharmaceuticals Inc.  17.30 
Anavex Life Sciences Corp.  16.97 
Dyne Therapeutics Inc.  16.88 
Neoleukin Therapeutics Inc.  16.86 
Ocugen Inc.  16.60 
Immunovant Inc.  16.21 
Candel Therapeutics Inc.  15.17 
Assembly Biosciences inc.  15.14 
Forma Therapeutics Holdings Inc.  15.10 
Oncternal Therapeutics Inc.  15.04 
Acasti Pharma Inc.  14.74 
In8bio Inc.  14.73 
Humacyte Inc.  14.70 
Bionano Genomics Inc.  14.33 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMCR's Profile

Stock Price

AMCR's Financials

Business Description

Fundamentals

Charts & Quotes

AMCR's News

Suppliers

AMCR's Competitors

Customers & Markets

Economic Indicators

AMCR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071